Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 9, 2009

View Archived Issues

Preclinical and phase I data on PI3 and mTOR kinase inhibitor GDC-0980 presented

Lentiviral vector gene therapy for X-linked adrenoleukodystrophy / News in Context

Selumetinib exhibits modest activity in AML in phase II trial

CORE trial data suggest efficacy of deferasirox in hereditary hemochromatosis

AJM-300 shows clinical activity in patients with active Crohn's disease

Preclinical and early phase I data suggest activity of JI-101 in solid tumors

Panacea Biotec claims novel compounds for the treatment of bacterial infections

Novel S1P1/edg1 receptor agonists in early development at Actelion

Takeda discloses novel ACC inhibitors for the treatment of obesity

Intellikine describes novel PI3K and mTOR inhibitors for the treatment of cancer

Novel GK activators claimed by Roche as antidiabetic agents

Alkermes licenses Medifusion technology platform from Acceleron

BioAlliance Pharma reports phase II survival data on doxorubicin Transdrug

Curis reports preclinical data on HSP 90 inhibitor CUDC-305

Stockholders approve Anesiva merger with Arcion Therapeutics

FDA approves initiation of clinical studies of Taro's T-2000 in the U.S.

Neoprobe's Lymphoseek achieves primary endpoint in phase III trial

Allos Therapeutics forms agreement with Idis for Folotyn

Janssen-Cilag submits MAA in Europe for paliperidone palmitate for schizophrenia

Oxygen Biotherapeutics enrolls first patient in Oxycyte trial in traumatic brain injury

Pharmaxis reports sustained benefit with Bronchitol in phase III trial in cystic fibrosis

Phase I/II clinical data reported for BiondVax's universal flu vaccine

Pluristem Therapeutics doses first patients in Europe with placenta-derived cell therapy

Provectus reports phase II data for PH-10 in psoriasis and atopic dermatitis

Roche to discontinue development of RG-1507

Radient receives Korean approval for its in vitro diagnostic cancer test Onko-Sure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.